IRISanRaf

BARBANTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.821
AS - Asia 2.746
EU - Europa 821
SA - Sud America 396
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 59
OC - Oceania 13
Totale 7.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.351
TR - Turchia 1.053
SG - Singapore 817
CN - Cina 496
CA - Canada 446
IT - Italia 350
BR - Brasile 315
VN - Vietnam 155
IE - Irlanda 71
UA - Ucraina 71
IN - India 67
DE - Germania 65
EU - Europa 65
GB - Regno Unito 56
RU - Federazione Russa 54
FI - Finlandia 35
HK - Hong Kong 33
AR - Argentina 30
ES - Italia 21
ID - Indonesia 21
NL - Olanda 21
MX - Messico 17
EC - Ecuador 16
SC - Seychelles 16
BD - Bangladesh 15
JP - Giappone 15
ZA - Sudafrica 14
FR - Francia 13
PK - Pakistan 13
SE - Svezia 11
AU - Australia 10
CO - Colombia 9
EG - Egitto 8
PL - Polonia 8
PY - Paraguay 7
VE - Venezuela 7
CL - Cile 6
IL - Israele 6
KE - Kenya 6
RO - Romania 6
CH - Svizzera 5
DZ - Algeria 5
IQ - Iraq 5
IR - Iran 5
KR - Corea 5
RS - Serbia 5
SA - Arabia Saudita 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
KZ - Kazakistan 4
MA - Marocco 4
PH - Filippine 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BW - Botswana 2
HN - Honduras 2
HR - Croazia 2
LT - Lituania 2
MN - Mongolia 2
MT - Malta 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
KH - Cambogia 1
LB - Libano 1
MY - Malesia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.923
Salva come PNG Salva come JPEG
Città #
Kocaeli 926
San Mateo 664
Dallas 622
Toronto 421
Wilmington 223
Rome 206
Santa Clara 190
Ashburn 187
Houston 181
Singapore 181
Lawrence 140
Princeton 140
Beijing 130
Fairfield 74
Ho Chi Minh City 64
Los Angeles 62
Seattle 54
Chandler 49
West Jordan 46
Redwood City 43
Shanghai 40
São Paulo 40
Hanoi 34
Woodbridge 34
New York 33
Hong Kong 31
Brooklyn 29
Guangzhou 26
Helsinki 25
Cambridge 24
Dublin 24
Frankfurt am Main 23
Milan 16
Shenzhen 13
Vicenza 13
Council Bluffs 11
London 11
Munich 11
Tokyo 11
Chicago 10
Montreal 10
Rio de Janeiro 10
Suffern 10
Atlanta 9
Haiphong 9
Boston 8
Denver 8
Mexico City 8
Saint Petersburg 8
San Francisco 8
Andover 7
Charlotte 7
Johannesburg 7
Quito 7
Rui'an 7
Secaucus 7
The Dalles 7
Turku 7
Wuhan 7
Ankara 6
Curitiba 6
Islamabad 6
Nairobi 6
Philadelphia 6
Phoenix 6
St Petersburg 6
Warsaw 6
Washington 6
Wuxi 6
Amsterdam 5
Ann Arbor 5
Belo Horizonte 5
Borås 5
Jiaxing 5
Kansas City 5
Manchester 5
Miami 5
Pune 5
Quanzhou 5
Xi'an 5
Almaty 4
Biên Hòa 4
Buenos Aires 4
Buffalo 4
Chennai 4
Columbus 4
Da Nang 4
Dhaka 4
Durban 4
Florence 4
Fontebuona 4
Guayaquil 4
Ha Long 4
Karachi 4
Kyiv 4
Medellín 4
Nanjing 4
Nantong 4
Paris 4
Pelotas 4
Totale 5.408
Salva come PNG Salva come JPEG
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 312
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 124
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 117
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 102
A case-control study on excessive daytime sleepiness in chronic migraine 92
A case - control study on excessive daytime sleepiness in episodic migraine 90
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 88
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 86
A case-control study on excessive daytime sleepiness in chronic migraine 86
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 84
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 81
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 78
Hypertension as a risk factor for migraine chronification 69
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 68
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 67
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 65
Acupuncture in cluster headache: Four cases and review of the literature 65
Unilateral cranial autonomic symptoms in migraine 63
Acute pathological laughter induced by sumatriptan 63
Restless legs syndrome is not associated with migraine with aura: a clinical study 62
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 62
Migraine as a Cortical Brain Disorder 62
A mechanism-based classification of pain in multiple sclerosis 61
Ketogenic diet in migraine: rationale, findings and perspectives 59
Late motor recovery is influenced by muscle tone changes after stroke 59
Migraine and Tourette syndrome 59
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 59
Pharmacotherapy for acute migraines in children and adolescents 59
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 58
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 58
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 57
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 57
Machine learning approach to predict medication overuse in migraine patients 57
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 57
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 56
Dopamine hypersensitivity in migraine: Role of the apomorphine test 56
Tardive dyskinesias in the elderly 56
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 56
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 56
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 55
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 55
Dopamine and migraine: Does Parkinson's disease modify migraine course? 55
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 55
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire 55
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 54
Treatment of tension-type headache: from old myths to modern concepts 54
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 54
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 53
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 53
Cluster headache: management of acute attacks before triptans 53
A proposal for a national registry on chronic migraines 53
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 52
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 52
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 52
Migraine and movement disorders 52
Tension type headache: a neuropsychological and neurophysiological study 52
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 52
Erenumab during pregnancy: a case report in a patient with chronic migraine 52
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 51
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 51
Donepezil in the treatment of progressive supranuclear palsy 51
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 51
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 51
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 51
Real-world insights on the management of migraine patients: an Italian nationwide study 51
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 50
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 49
Shortened cortical silent period in facial muscles of patients with migraine 49
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 49
Migraine prophylaxis: what is new and what we need? 49
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 48
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 48
Migraine and the extrapyramidal system 48
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 48
Migraine attack delays gastric emptying: an ultrasonographic study 47
Trigeminal sensory pathway function in patients with SUNCT 47
Drugs targeting nitric oxide synthase for migraine treatment 47
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 47
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 47
Future trends in drugs for migraine prophylaxis 47
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 47
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 46
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 46
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 46
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 45
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 45
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 45
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 44
CEP Cortelli Corrigendum for 515342 (vol 34, pg 434, 2014) 44
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 44
Use of dopamine agonists in aged patients with Parkinson's disease 44
Impairment of trigeminal sensory pathways in cluster headache 44
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 44
Unilateral Cranial Autonomic Symptoms in Migraine: A Retrospective Case Series on 757 Patients 44
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 43
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project 43
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 42
Headache in chronic cocaine users: A cross-sectional study 42
The role of dopamine in migraine 42
Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications 42
Totale 5.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.293 0 0 0 0 0 78 58 35 47 73 940 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/20262.295 259 356 662 381 269 368 0 0 0 0 0 0
Totale 8.155